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474a Tuesday, February 18, 2014non-enzymatic, post-translational protein modifications such as racemization
and isomerization. While in many cases aged or non-enzymatically damaged
proteins can be repaired or replaced, some changes can inhibit protein turn-
over resulting in an accumulation of damaged protein over time. One of the
modifications that very-long lived proteins have been shown to undergo is
racemization of aspartic acid and asparagine residues to the non-natural D-
form from the common L-form via succinimide intermediate. In this study
we have employed quantitative label-free mass spectrometry to study isom-
erization/racemization reactions site specifically in the repeat-1 domain of
Tau protein. We found that Asp-265 isomerizes into four different isoforms.
We also found that the Tau peptide undergoes an auto-catalytic cleaveage
without the use of a protease. A possible mechanism for the formation of
the four isomers is proposed. This data may provide useful information on
the in vivo rates of tau racemization, providing insights into the mechanisms
and potentially opening a door to finding biomarkers for Alzheimer’s
disease.
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Cyanovirin-N (CVN) is a cyanobacterial lectin with potent anti-HIV activity,
mediated by binding to Man(1,2)Man with high affinity and specificity. These
sugar-binding sites are located in two quasi-symmetric domains (A and B) of
the CVN protein. We explore both the evolutionary and functional dynamics
of CVN and reengineer CVN mutants with different binding affinity for the
oligo-mannosides, through integrated computational and experimental strate-
gies. We perform statistical analysis on CVN homologs to find correlated mu-
tations between amino acids1 and in parallel; we also analyze the positions
whose correlated fluctuations are critical for function through a dynamic flex-
ibility index (dfi) metric.2 Integrating the evolutionary information with the
dynamically coupled positions that are critical for function, we model various
CVNmutants and obtain these variants in complex with di-mannose sugar with
a fast and flexible docking method called BP-Dock.3 We later characterize
these mutants experimentally with NMR or ITC. Overall, this study helps us
to explore the sugar binding properties of CVN mutants obtained from evolu-
tionary and functional analysis and thus provide better insights about the mech-
anism of glycan recognition.
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Sepsis, blood poisoning, is a complex and severe infectious disease with high
mortality (25~50%). Up to date, sepsis remains a therapeutic dilemma despite
some advances in drug therapy and intensive care. In the case of Gram-negative
bacteria, endotoxins (lipopolysaccharides, LPS) are major components and
well known to be responsible for the strong inflammation reaction resulting
in systemic infection. Other cytokines, such as TNF-a released from LPS-
activated macrophages, IL-6, and IL-1b, also have much influence on the sepsis
disease.
The purpose of this study was to de novo design the anti-inflammatory pep-
tides for capturing the LPS, TNF-a, IL-6, and IL-1b in the blood of patients
with severe sepsis to reduce their concentrations. The peptides determined
from the cytokine-receptor complexes binding sites (from Protein Data
Bank) were firstly used for docking to validate the selected peptide-
cytokine binding. These peptides were then modified as de novo design to
search for preferable binding affinity. The binding free energies of these
peptide-cytokine complexes were calculated for comparison. The de novo de-
signed peptides can be synthesized for further bio-assay and then applied to
manufacture a cytokines adsorber for treating patients with severe sepsis in
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Type VII protein secretion (T7S) systems are found among numerous bacte-
rial species, and have been implicated in a wide range of functions including
growth, nutrient uptake, and virulence. The pathogenic bacterium Mycobac-
terium tuberculosis, the etiologic agent of tuberculosis disease, contains
five T7S systems, termed ESX-1 through ESX-5. Importantly, virulence is
entirely dependent on ESX-1; while another system, ESX-3, is essential for
growth and viability. While every T7S system contains a translocase,
EccC, and a heterodimeric substrate, EsxAB, individual knockouts of proteins
within a specific system in M. tuberculosis are not compensated for by the
remaining four paralogs in vivo. Thus, at least some substrates, including
EsxA and EsxB, are specific to individual ESX systems. How substrates
are selected by T7S systems, and how these substrates are distinguished by
different T7S systems within a single organism, is currently unknown and
could be important for drug and vaccine development. We investigated the
question of substrate selectivity using biochemical and genetic techniques.
Importantly, we solved the first crystal structure of the EsxAB heterodimer
that includes two regions important for substrate binding, including a
hitherto-unseen C-terminal helix on EsxB. We further identified several res-
idues that are absolutely necessary for binding of substrate to EccC, and have
determined that seven of them together encode the information required for
specificity.
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In Nature arsenate can in principle replace phosphate in its role as a key bio-
logical molecule (e.g. as in ATP) but arsenate analogues are less stable with
respect to hydrolysis and reduction. Yet bacterial adoption of arsenic has
been described and although the precise nature of the arsenic species is un-
determined, it is possible that arsenate is incorporated as direct substitution
for phosphate in cellular macromolecules. Several phosphate-binding pro-
teins are able to selectively bind phosphate over arsenate despite their chem-
ical similarities. We take advantage of this chemical similarity to elucidate
arsenate-phosphate discrimination and to probe our understanding of
phosphate-binding mechanisms in general. Specifically we consider a highly
flexible synthetic hexapeptide capable of irreversibly binding phosphate as
well as a number of highly selective phosphate binding proteins, including
those with the evolutionarily conserved sequence known as a P-loop. A ma-
jor challenge in structural analysis is that automatic ligand search methods
are deemed to fail in detecting phosphate-binding sites in small and disor-
dered phosphate-binding peptides. We use the Generalized Amber Force
Field (GAFF) and extend it to include arsenate. Our ability to explore and
explain experimental results using a combination of DFT, MD, and
MCMC techniques are demonstrated in their ability to distinguish between
the chemically close phosphate and arsenate ligands. Using a number compu-
tational techniques, we explore the large number of potential interactions that
may be exploited to explain and control the specificity and selectivity of
binding.
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The recent increase in antibiotic resistance in disease-causing bacteria calls
for new approaches to drug target selection and drug development. Targeting
proteins involved in the bacterial cell division process provides a novel
mechanism of action that bypasses problems associated with the increasingly
ineffective variants of older antibiotics. One potentially powerful target for
inhibition is the bacterial cytoskeletal protein FtsZ, a GTPase homolog of
eukaryotic tubulin. This highly conserved and essential protein acts as a
scaffold to recruit other cell division machinery and can exert mechanical
forces that may be responsible for constriction of the division site. Recent
work on an allosteric inhibitor (PC190723) has shown promising in vitro
and in vivo antimicrobial activities on Staphylococcus aureus, however the
